IME — Imagin Medical Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Imagin Medical, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.01 | 4.55 | 4.39 | 11.4 | 2.51 |
| Operating Profit | -8.01 | -4.55 | -4.39 | -11.4 | -2.51 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
| Net Income After Taxes | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.48 | -0.642 | -0.528 | -0.433 | -0.353 |